emeritipharma.se

Home

EP0003 - a novel mechanism. The plasminogen/plasmin system appears to be overactive in several dermatological conditions. By inhibiting the conversion of plasminogen to plasmin EP0003 can have beneficial effects on several skin diseases, offering new treatment opportunities. EP0003 is formulated as a cream for topical application and a Phase I study in rosacea is ongoing. We also plan to perform exploratory clinical studies in plaque psoriasis and melasma.

http://www.emeritipharma.se/

OVERVIEW OF emeritipharma.se

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

5

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR EMERITIPHARMA.SE

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

February

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 13 reviews

5 star

6

4 star

5

3 star

1

2 star

0

1 star

1

Hey there! Start your review of emeritipharma.se

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

0.8 seconds

CONTACTS AT EMERITIPHARMA.SE

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

5

SSL

EXTERNAL LINKS

1

SITE IP

46.30.213.65

LOAD TIME

0.828 sec

SCORE

6.2

PAGE TITLE

Home | emeritipharma.se Reviews

<META> DESCRIPTION

EP0003 - a novel mechanism. The plasminogen/plasmin system appears to be overactive in several dermatological conditions. By inhibiting the conversion of plasminogen to plasmin EP0003 can have beneficial effects on several skin diseases, offering new treatment opportunities. EP0003 is formulated as a cream for topical application and a Phase I study in rosacea is ongoing. We also plan to perform exploratory clinical studies in plaque psoriasis and melasma.

<META> KEYWORDS

1 about us

2 investors

3 news

4 emeriti pharma

5 for treatment of

6 dermatological disorders

7 rosacea

8 psoriasis

9 melasma

10 phase i

CONTENT

Page content here

KEYWORDS ON PAGE

about us,investors,news,emeriti pharma,for treatment of,dermatological disorders,rosacea,psoriasis,melasma,phase i

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home | emeritipharma.se Reviews

https://emeritipharma.se

EP0003 - a novel mechanism. The plasminogen/plasmin system appears to be overactive in several dermatological conditions. By inhibiting the conversion of plasminogen to plasmin EP0003 can have beneficial effects on several skin diseases, offering new treatment opportunities. EP0003 is formulated as a cream for topical application and a Phase I study in rosacea is ongoing. We also plan to perform exploratory clinical studies in plaque psoriasis and melasma.

INTERNAL PAGES

emeritipharma.se

1

Home

http://www.emeritipharma.se/index.html

EP0003 - a novel mechanism. The plasminogen/plasmin system appears to be overactive in several dermatological conditions. By inhibiting the conversion of plasminogen to plasmin EP0003 can have beneficial effects on several skin diseases, offering new treatment opportunities. EP0003 is formulated as a cream for topical application and a Phase I study in rosacea is ongoing. We also plan to perform exploratory clinical studies in plaque psoriasis and melasma.

2

Project EP0003

http://www.emeritipharma.se/project%20ep0003.html

EP0003 A new treatment for dermatological disorders. The compound EP0003 was acquired from AstraZeneca in 2014. The IP protection is strong with granted patents in several territories, including USA. EP0003 is a low molecular compound. It is chemically very stable both in solid form and in solution. It is formulated in a cream for topical application. Rosacea - An opportunity for faster onset and improved efficiacy. A Phase I study with topical EP0003 is ongoing. Presently used drugs include metronidazol...

3

Investors

http://www.emeritipharma.se/investors.html

Results from the ongoing Phase I trial in rosacea are expected in March 2017. Phase Ib in plaque psoriasis. Phase Ib in an experimental melasma model. Phase IIa in a selected indication (require additional toxicological studies). The Phase I study in rosacea is fully financed with current investments from the founders, ALMI and Antaros AB. A partner for the further development of EP0003 is sought. The world market for rosacea is estimated to 1.2 billion USD.

4

About us

http://www.emeritipharma.se/Om.html

A privately owned Swedish company, was founded in 2014 by former AstraZeneca scientists representing a wide knowledge of pharmaceutical research and development, often with many years in leading positions, and with experience of taking innovative drugs to the market. Chairman of the Board, PhD in biochemistry, worked with AstraZeneca for 27 years, and Schering AG for 5 years. Co-founder of Emeriti Pharma. PhD in organic chemistry, worked with AstraZeneca for 25 years. Co-founder of Emeriti Pharma.

5

News

http://www.emeritipharma.se/news.html

2015-11-10 Almi invests in Emeriti Pharma. 2016-10-25 Phase I, first patient in. 2016-12-20 Antaros Medical and Almi Invest adds 3 million SEK in venture. Capital to Emeriti Pharma.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

5

OTHER SITES

emeriticourses.georgetown.edu

Georgetown University

Association of Main-Campus Retired Faculty. The Georgetown University Learning Community. Short non-credit courses on the Georgetown University Campus, for persons ‘55 or better.’. Preregistration is required. Class-size will be limited. Parking ($3/hour) in the South Parking Garage, entered from Canal Road. Registration fees are $30 for one course, $50 for two or more courses. Dues-paid members (and their spouses) of. The Association of Main-Campus Retired Faculty. Present or past GU Learning Community.

emeritifaculty.gwu.edu

Society of the Emeriti | The George Washington University

Skip to main content. Enter the terms you wish to search for. Virginia Science and Technology Campus. Online and Virginia Academic Centers. GWeb (Records and Registration). Division of Student Affairs. Colonial Central (Financial Services). GW Bulletin (Course Descriptions). Student Support and Family Engagement. The George Washington University Society of the Emeriti (SOTE) works to help maintain close ties between the University and former faculty. James E. Kee. Associate Professor Emeritus of English.

emeritihealth.org

Emeriti Health Homepage | Emeriti Retirement Health

Skip to main content. Emeriti board of trustees. Retirement health savings program (RHSP). Special purpose medical insurance plan. Trust administration and investments. Insurance enrollment and premium collection. Compliance and regulatory support. Partnering with Emeriti and TIAA. How We Help You. Tools you can use. Check health account balance. Hit enter to search. Hit enter to search. How We Help You. Emeriti board of trustees. Retirement health savings program (RHSP). Compliance and regulatory support.

emeritimanagement.com

Welcome emeritimanagement.com - Justhost.com

Web Hosting from Just Host. Design By Design Fusions.

emeritimgt.com

Emeriti Management Inc. | Business Consulting and Leadership Coaching

Business Consulting and Leadership Coaching. Re-launch date July 15, 2015. See you then! Proudly powered by WordPress.

emeritipharma.se

Home

EP0003 - a novel mechanism. The plasminogen/plasmin system appears to be overactive in several dermatological conditions. By inhibiting the conversion of plasminogen to plasmin EP0003 can have beneficial effects on several skin diseases, offering new treatment opportunities. EP0003 is formulated as a cream for topical application and a Phase I study in rosacea is ongoing. We also plan to perform exploratory clinical studies in plaque psoriasis and melasma.

emeritiprogram.com

The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).

emeritis.com

Emeritis EMEA : EMEA

We transform your people strategy to realize corporate goals, enabled by best-in-market HR technology. Event - April 16, 2018. Join us at the Ekonomika Job Fair in Leuven to discuss your career opportunities! We look forward to meeting you! For questions or information, please contact our recruitment specialist: petra.verlaak@emeritis.com. From optimized HR Reporting and Dashboarding to Advanced Analytics insights using data and machine learning: we provide evidence to support your HR Initiatives. Our pr...

emerito.co.uk

Emerito Limited - IT Support &amp Services

Emerito Limited - IT Support &amp Services. Already Have a Network. Network Design and Implementation. Integrated Voice and Data. Remote Access and Home Workers. Reports, Data Mining and Extraction. Website Hosting &amp Email. IT support and services for businesses throughout London and the South East. We know that to many small businesses computers can seem incredibly complicated. Tel: 0870 233 6840. Email: info@emerito.co.uk.

emerito.com

Emerito - Tecnología alimentaria

Emerito, Food Technology. 2011 Emerito S.L. T 34 948 68 51 07.

emerito.org

Hostnet: De grootste domeinnaam- en hostingprovider van Nederland.

Alles voor ondernemend Nederland. Wil jij ook zo'n unieke domeinnaam? Check of jouw domein nog vrij is:. Inbegrepen bij je domeinnaam. Stuur je mail door naar een ander e-mailadres. Maak eenvoudig je eigen miniwebsite. Verwijs je domeinnaam door naar een website. Hostnet registreerde met succes al meer dan 2 miljoen domeinnamen.